Holen Sie sich die Stockscreener-App
80.28
0.21%
-0.17
Schlusskurs vom Vortag:
$80.45
Offen:
$79.58
24-Stunden-Volumen:
282.76K
Relative Volume:
0.79
Marktkapitalisierung:
$1.84B
Einnahmen:
$256.28M
Nettoeinkommen (Verlust:
$62.40M
KGV:
29.58
EPS:
2.7139
Netto-Cashflow:
$79.12M
1W Leistung:
+0.40%
1M Leistung:
-20.77%
6M Leistung:
-25.79%
1J Leistung:
-15.82%
1-Tages-Spanne:
$79.05
$80.95
1-Wochen-Bereich:
$78.27
$80.97
52-Wochen-Spanne:
$78.27
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
80.28 | 1.88B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Summit Creek Advisors LLC Buys New Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Bank of America Corp DE Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Rice Hall James & Associates LLC Purchases Shares of 189,907 LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT Q2 2026 Earnings: EPS Misses Estimates as Stock Holds Modest DeclinePre-Earnings Setup - vinanet.vn
LeMaitre Vascular (LMAT) Edges Higher to $82.38, Holding Ground Above Key SupportMean Reversion Trade - vinanet.vn
LeMaitre Vascular (LMAT) Advances Modestly to $82.38 as Range-Bound Trading PersistsDaily Profile - dars.gov.et
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular (LMAT) Holds Steady Near $82 as Medtech Sector Shows ResilienceVolume Nodes - Vinanet
How Investors May Respond To LeMaitre Vascular (LMAT) Trimmed 2026 Outlook Despite Higher Q2 Sales - simplywall.st
Price performance - Yahoo Finance Australia
LeMaitre Vascular remains a Buy despite 31% pul... - Pluang
LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT) - Seeking Alpha
The Technical Signals Behind (LMAT) That Institutions Follow - Stock Traders Daily
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 39% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call - The Globe and Mail
Quantinno Capital Management LP Buys 18,204 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Has A Fresh Update, So Why Is It Drawing Attention? - Sahm
31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update - Yahoo Finance
LeMaitre Vascular, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - simplywall.st
LeMaitre Vascular (LMAT) Hit by Profit Taking - AlphaStreet
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - The Manila Times
LeMaitre management to meet investors at virtual Aug. 11 event - Stock Titan
LeMaitre Vascular sales increase 10% to USD 70.4M in Q2 2026 - Medical Buyer
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95 - Yahoo Finance
Stocks making big moves yesterday: LeMaitre, ePlus, Booking, Paymentus, and Vishay Intertechnology - theglobeandmail.com
LMAT SWOT Analysis: Strong Financial Growth and Market Position Revealed in 10-Q Filing - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year Low on Analyst Downgrade - MarketBeat
LeMaitre Vascular stock hits 52-week low at 79.38 USD By Investing.com - Investing.com Nigeria
LeMaitre Vascular stock hits 52-week low at 79.38 USD - Investing.com
LeMaitre Vascular Down Over 22%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk - Moomoo
LMAT Looks 15.2% Undervalued on GF Value™ Despite Recent Sharp P - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Cut to $94.00 by Analysts at Wells Fargo & Company - MarketBeat
Why LeMaitre (LMAT) Shares Are Getting Obliterated Today - TradingView
Why is LeMaitre Vascular stock tumbling today? By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down on Disappointing Earnings - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research - MarketBeat
LeMaitre Vascular, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform - Yahoo Finance
Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside - TradingView
LeMaitre Vascular Announces Q2 2026 Earnings with Increased Sales and Net Income - Kalkine Media
LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ... - Yahoo Finance
LEMAITRE VASCULAR, INC. : BARRINGTON RESEARCH CUTS TO MARKET PERFORM FROM OUTPERFORM - Bitget
LeMaitre Vascular Q2 Earnings Call Highlights - MarketBeat
Is LeMaitre Vascular Inc (LMAT) Overvalued After Q2 Earnings Mis - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results - marketbeat.com
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates - finance.yahoo.com
LeMaitre Vascular (NASDAQ:LMAT) Releases Q4 2026 Earnings Guidance - MarketBeat
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lemaitre Vascular Inc-Aktie (LMAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LeMaitre George W | Chairman and CEO |
May 08 '26 |
Sale |
108.69 |
27,881 |
3,030,400 |
1,430,019 |
| LeMaitre George W | Chairman and CEO |
May 07 '26 |
Sale |
107.64 |
18,600 |
2,002,013 |
1,457,900 |
| Kamke Trent G | Senior V. P., Operations |
May 08 '26 |
Sale |
107.00 |
2,928 |
313,287 |
3,749 |
| Ross Bridget A | Director |
May 07 '26 |
Option Exercise |
48.15 |
5,044 |
242,882 |
8,986 |
| Ross Bridget A | Director |
May 07 '26 |
Sale |
111.10 |
5,044 |
560,366 |
3,942 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Option Exercise |
65.92 |
2,858 |
188,412 |
8,657 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Sale |
110.00 |
3,943 |
433,730 |
4,714 |
1.40%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):